Roche plans to steer clear of the wave of big takeovers sweeping through the healthcare industry and focus instead on small acquisitions and partnerships, the Swiss drugmaker's chief executive said in an inte
Roche’s pharmaceuticals division has promoted Ehab Yousef to the newly created role of sub-region head for Middle East, overseeing the market activities in GCC region, Egypt and Yemen.
Tthe move results from an effort by the
Roche Diagnostics, the diagnostics division of healthcare company Roche, has recorded a seven per cent increase in overall sales.
The division’s clinical labs business saw the biggest growth, recording a
Roche Diagnostics Middle East demonstrated ‘in vitro’ diagnostics (IVD) and how it adds value to disease management, treatment choices and cost at the ongoing Arab Health Congress in Dubai.
Illustrated via a Medical Va
Swiss drugmaker Roche has found an efficient way for complex antibody drugs to reach and penetrate the brain, raising the possibility of more effective treatments for diseases such as Alzheimer's.
The innovative brain shuttle
Swiss drugmaker Roche will pay up to 500 million Swiss francs ($548 million) for an experimental antibiotic, marking a rare foray by a major pharmaceutical firm into the battle against so-called "superbug" infections found in hospitals
An experimental drug that mimics the effects of two naturally occurring hormones appears to work significantly better than existing single-hormone medicines against diabetes and obesity, scientists said.
A team of German and US-ba
US health regulators expanded the approval of Roche Holding's breast cancer drug Perjeta and will now allow its use to help shrink tumors prior to surgery, the Food and Drug Administration said on Monday.
The decision followed
Roche Holding's cancer drug Avastin has been rejected by Britain's healthcare cost agency as a first-line treatment for advanced breast cancer, the latest in a series of setbacks for this medicine.
The National Institute for Health and Cli